Giuseppe Mastrangelo

Dr. Giuseppe Mastrangelo

orcid

Research Focus & Metrics

Academic Career Length

28Years (1999-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2005 in Occupational Medicine
Verified
Journal Article
Open access
PDF file
GMGiuseppe Mastrangelo
Giuseppe Mastrangelo
UFUgo Fedeli
Ugo Fedeli
EFEmanuela Fadda
Emanuela Fadda
AGAngelo Giovanazzi
Angelo Giovanazzi
LSLuca Scoizzato
Luca Scoizzato
BSBruno Saia
Bruno Saia
Background Five cancer cases over 7 years were reported in a small orthopaedic hospital where radiation protection practice was poor. Aim To investigate whether workers subject to routine radiation dosimetric assessment in that hospital had an increased cancer risk. Methods One hundred and fifty-eight workers subject to routine dose assessment and 158 age–sex-matched unexposed workers were questioned about cancer occurrence. All tumours were analysed as a single diagnostic category. Results Cumulative 1976–2000 cancer incidence was 29 (9/31), 6 (8/125) and 4% (7/158) in orthopaedics, exposed other than orthopaedics, and unexposed workers, respectively. At logistic regression analysis, working as orthopaedic surgeon significantly (P<0.002) increased the risk of tumours. Conclusion These findings caution against surgeons' underestimation of the potential radiation risk and insufficient promotion of safe work practices by their health care institutions.

22 February 2013 in Marine Drugs
Verified
Journal Article
Open access
PDF file
Luca CegolonLuca Cegolon
Luca Cegolon
WHWilliam C. Heymann
William C. Heymann
JLJohn Lange
John Lange
GMGiuseppe Mastrangelo
Giuseppe Mastrangelo
Jellyfish (cnidarians) have a worldwide distribution. Despite most being harmless, some species may cause local and also systemic reactions. Treatment of jellyfish envenomation is directed at: alleviating the local effects of venom, preventing further nematocyst discharges and controlling systemic reactions, including shock. In severe cases, the most important step is stabilizing and maintaining vital functions. With some differences between species, there seems to be evidence and consensus on oral/topical analgesics, hot water and ice packs as effective painkillers and on 30 s application of domestic vinegar (4%–6% acetic acid) to prevent further discharge of unfired nematocysts remaining on the skin. Conversely, alcohol, methylated spirits and fresh water should be carefully avoided, since they could massively discharge nematocysts; pressure immobilization bandaging should also be avoided, as laboratory studies show that it stimulates additional venom discharge from nematocysts. Most treatment approaches are presently founded on relatively weak evidence; therefore, further research (especially randomized clinical trials) is strongly recommended. Dissemination of appropriate treatment modalities should be deployed to better inform and educate those at risk. Adequate signage should be placed at beaches to notify tourists of the jellyfish risk. Swimmers in risky areas should wear protective equipment.

9 August 2007 in BMC Public Health
Verified
Journal Article
Open access
PDF file
GMGiuseppe Mastrangelo
Giuseppe Mastrangelo
UFUgo Fedeli
Ugo Fedeli
CVCristiana Visentin
Cristiana Visentin
GMGiovanni Milan
Giovanni Milan
EFEmanuela Fadda
Emanuela Fadda
PSPaolo Spolaore
Paolo Spolaore
Numerous studies have investigated mortality during a heatwave, while few have quantified heat associated morbidity. Our aim was to investigate the relationship between hospital admissions and intensity, duration and timing of heatwave across the summer months.

1 May 2002 in Toxicology and Industrial Health
Verified
Journal Article
Closed access
GMGiuseppe Mastrangelo
Giuseppe Mastrangelo
UFUgo Fedeli
Ugo Fedeli
EFEmanuela Fadda
Emanuela Fadda
GMGiovanni Milan
Giovanni Milan
JLJohn H Lange
John H Lange
A meta-analysis of epidemiologic studies for textile industry workers was undertaken in an attempt to evaluate whether the cancer risk varies within the textile industry in relation to the job held or the textile fiber used. We combined studies published up until 1990, when an ad hoc IARC Monograph was issued, and those published after 1990 with the aim of appreciating evidence of reversing trends in cancer risk. Observed and expected cases reported in the original studies were summed up and the totals were divided to obtain a pooled relative risk (PRR) with a 95% confidence interval (CI) estimated with a fixed-effect model. We calculated a chi-square test (x2) of heterogeneity among studies. When PRR and x2 were both significant, PRR and CI were calculated with a random-effect model and the source of heterogeneity was investigated. Lung cancer risk was around 0.4 in the first study on cotton workers published in 1936, around 0.7 in subsequent studies, mostly published in the 1970s and 1980s, and around 1.0 in the last studies published in the 1990s. Papers published in the 1970s and 1980s produced consistent risk estimates for lung cancer risk, which was significantly lower than 1.0 in workers exposed to cotton (PRR 3/4-0.77; CI3/4-0.69-0.86) and wool dust (0.71; 0.50-0.92), as well as in carders and fiber preparers (0.73; 0.54-0.91), weavers (0.71; 0.56-0.85), and spinners and weavers (0.78; 0.66-0.91). Lung cancer PRRs did not significantly deviate from 1.0 in textile workers using synthetic fibers or silk, and in dyers. Increased PRRs were found for sinonasal cancer in workers exposed to cotton dust, and in workers involved in spinning or weaving (4.14; 1.80-6.49). PRR was 1.46 (1.10-1.82) for cancer of the digestive system in textile workers using synthetic fibers or silk, and 1.34 (1.10-1.59) for colorectal cancer in spinners and weavers. The increased bladder cancer PRR in dyers (1.39; 1.07-1.71) is generally attributed to textile dye exposure. In studies published after 1990, there is a general tendency to move toward unity for all the cancer risk estimates, leading to an increasing heterogeneity among studies. Since adjustment for smoking made little difference to the findings, the latter could be attributed to the exposure to textile dusts. The recent findings could be due to a lowering of dust concentration in the workplaces. The reduction of cases of upper respiratory tract cancer parallels with a corresponding increase of lung cancer cases. So, preventive measures have paradoxically increased the lung cancer burden to the textile workers.

1 August 2004 in Environmental Health Perspectives
Verified
Journal Article
Closed access
GMGiuseppe Mastrangelo
Giuseppe Mastrangelo
UFUgo Fedeli
Ugo Fedeli
EFEmanuela Fadda
Emanuela Fadda
FVFlavio Valentini
Flavio Valentini
RARoberto Agnesi
Roberto Agnesi
DMDiego Martines
Diego Martines

3 January 2013 in BMC Cancer
Verified
Journal Article
Open access
PDF file
Luca CegolonLuca Cegolon
Luca Cegolon
Cristiano SalataCristiano Salata
Cristiano Salata
EWElisabete Weiderpass
Elisabete Weiderpass
PVPaolo Vineis
Paolo Vineis
Giorgio  PalùGiorgio Palù
Giorgio Palù
GMGiuseppe Mastrangelo
Giuseppe Mastrangelo
Cancer is a significant and growing problem worldwide. While this increase may, in part, be attributed to increasing longevity, improved case notifications and risk-enhancing lifestyle (such as smoking, diet and obesity), hygiene-related factors resulting in immuno-regulatory failure may also play a major role and call for a revision of vaccination strategies to protect against a range of cancers in addition to infections. Human endogenous retroviruses (HERVs) are a significant component of a wider family of retroelements that constitutes part of the human genome. They were originated by the integration of exogenous retroviruses into the human genome millions of years ago. HERVs are estimated to comprise about 8% of human DNA and are ubiquitous in somatic and germinal tissues. Physiologic and pathologic processes are influenced by some biologically active HERV families. HERV antigens are only expressed at low levels by the host, but in circumstances of inappropriate control their genes may initiate or maintain pathological processes. Although the precise mechanism leading to abnormal HERVs gene expression has yet to be clearly elucidated, environmental factors seem to be involved by influencing the human immune system. HERV-K expression has been detected in different types of tumors. Among the various human endogenous retroviral families, the K series was the latest acquired by the human species. Probably because of its relatively recent origin, the HERV-K is the most complete and biologically active family. The abnormal expression of HERV-K seemingly triggers pathological processes leading to melanoma onset, but also contributes to the morphological and functional cellular modifications implicated in melanoma maintenance and progression. The HERV-K-MEL antigen is encoded by a pseudo-gene incorporated in the HERV-K env-gene. HERV-K-MEL is significantly expressed in the majority of dysplastic and normal naevi, as well as other tumors like sarcoma, lymphoma, bladder and breast cancer. An amino acid sequence similar to HERV-K-MEL, recognized to cause a significant protective effect against melanoma, is shared by the antigenic determinants expressed by some vaccines such as BCG, vaccinia virus and the yellow fever virus. HERV-K are also reactivated in the majority of human breast cancers. Monoclonal and single-chain antibodies against the HERV-K Env protein recently proved capable of blocking the proliferation of human breast cancer cells in vitro, inhibiting tumor growth in mice bearing xenograft tumors. A recent epidemiological study provided provisional evidence of how melanoma risk could possibly be reduced if the yellow fever virus vaccine (YFV) were received at least 10 years before, possibly preventing tumor initiation rather than culling melanoma cells already compromised. Further research is recommended to confirm the temporal pattern of this protection and eliminate/attenuate the potential role of relevant confounders as socio-economic status and other vaccinations. It appears also appropriate to examine the potential protective effect of YFV against other malignancies expressing high levels of HERV-K antigens, namely breast cancer, sarcoma, lymphoma and bladder cancer. Tumor immune-therapy, as described for the monoclonal antibodies against breast cancer, is indeed considered more complex and less advantageous than immune-prevention. Cellular immunity possibly triggered by vaccines as for YFV might also be involved in anti-cancer response, in addition to humoral immunity.